Pfizer’s Revolutionary Hemophilia B Gene Therapy Gains FDA Approval and Introduces Unique Warranty Program

Pfizer, FDA, Hemophilia B, Gene Therapy, Approval, Warranty, Treatment, Genetic Disorder, Blood Clotting, Healthcare, Biotechnology

FDA Approves Pfizer’s Hemophilia B Gene Therapy with a $3.5 Million Price Tag

Pfizer, FDA, hemophilia B, gene therapy, approval, pricing, healthcare, biotechnology, rare diseases, genetic disorders, treatment cost.

Regeneron Pharmaceuticals Expands Gene Editing Capabilities with Mammoth Biosciences Partnership

Regeneron, Mammoth Biosciences, gene editing, CRISPR, partnership, biotechnology, healthcare, pharmaceuticals, genetic research, therapeutic development.

Revolutionizing Women’s Healthcare: GE HealthCare Unveils AI-Driven, Voice-Activated Ultrasound Machines

GE HealthCare, voice-activated, AI-powered, ultrasound machines, women’s health, healthcare innovation, medical technology, diagnostic imaging, obstetrics, gynecology.